Biotech company COMPASS Pathways has produced a drug to treat depression based on the psychedelic substance found in magic mushrooms. Bruce Packard assesses the stock's potential for investors.
from Moneyweek RSS Feed https://moneyweek.com/investments/stocks-and-shares/share-tips/605302/a-uk-based-biotech-stock-aiming-to-beat-depression
via IFTTT
Subscribe to:
Post Comments (Atom)
-
The new strain of covid found in South Africa could disrupt plans by governments and central banks to rebuild economies. Financial markets a...
-
Fidelity “FIS” is a global financial services technology company and a leader in providing technology solutions to merchants, banks and cap...
-
Asian Equities Sink on Covid FearsIt’s been a mixed start to the week for global equities benchmarks with US and European asset markets rema...
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.